Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat

The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 2007-05, Vol.205 (1), p.36-47
Hauptverfasser: Breit, S., Bouali-Benazzouz, R., Popa, R.C., Gasser, T., Benabid, A.L., Benazzouz, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 47
container_issue 1
container_start_page 36
container_title Experimental neurology
container_volume 205
creator Breit, S.
Bouali-Benazzouz, R.
Popa, R.C.
Gasser, T.
Benabid, A.L.
Benazzouz, A.
description The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an early and in an advanced stage PD rat model. 6-Hydroxydopamine (6-OHDA) injection into the striatum induced a partial lesion of dopamine cells in the substantia nigra pars compacta (SNc) and fibers in the striatum. The GP firing rate decreased significantly with no significant change of the pattern. 6-OHDA injection into the SNc induced a total or subtotal lesion without any change in the firing rate and patterns of GP neurons. Concerning the STN, after partial lesion, the firing rate remained unchanged but the firing pattern significantly changed towards a more irregular and bursty pattern. In rats with total or subtotal lesion of the SNc the firing rate increased significantly and the relative amount of tonic neurons significantly decreased. Our results demonstrate that neuronal reactivity in the basal ganglia network considerably differs in the early versus late stage model of PD. We showed that the pathological activity of STN neurons after severe lesion is not mediated by the GP. Moreover, the unchanged activity of GP neurons is likely to be a consequence of the STN hyperactivity. These data suggest that in the GP-STN-GP network, the excitatory influence of the STN-GP pathway overrides that of the GABAergic GP-STN pathway, questioning the classical model of basal ganglia organization.
doi_str_mv 10.1016/j.expneurol.2006.12.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19372621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488606006534</els_id><sourcerecordid>19372621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-575a254b81f62f73cac0783bee82261c92f30b0e214392f36b8d4e6a1a01e6b73</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxi1ERbeFV4Bc4JbgP4mTHKuqpZUqcaFna-JMWC_eONjOtnkY3hWnu6JHTrbm-32eGX-EfGK0YJTJr7sCn6cRZ-9swSmVBeNFqr8hG0ZbmvNS0LdkQykr87Jp5Dm5CGFHKW1LXr8j56wWbcUatiF_boYBdQyZGzKZb5feu-eldxPszYi5GftZY58FPKDHzPlsAh8N2MxiMG5cXXGL2Wh-eheiNxCTNkHcPsGSJf1FXMccUx10NAcTl9U1gbWmd3mYu7gFm9rpBMYn539l5ujzEN-TswFswA-n85I83t78uL7LH75_u7--esh1WjTmVV0Br8quYYPkQy00aFo3okNsOJdMt3wQtKPIWSnWu-yavkQJDChD2dXiknw5vjt593vGENXeBI3WwohuDoq1ouaSswTWR1CnfYPHQU3e7MEvilG1JqN26l8yak1GMa5SPTk_nlrM3R77V98pigR8PgEQNNjBw6hNeOWauhKiWWe9OnKYPuRg0KugDY4pJuNTkqp35r_D_AWeO7Sz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19372621</pqid></control><display><type>article</type><title>Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Breit, S. ; Bouali-Benazzouz, R. ; Popa, R.C. ; Gasser, T. ; Benabid, A.L. ; Benazzouz, A.</creator><creatorcontrib>Breit, S. ; Bouali-Benazzouz, R. ; Popa, R.C. ; Gasser, T. ; Benabid, A.L. ; Benazzouz, A.</creatorcontrib><description>The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an early and in an advanced stage PD rat model. 6-Hydroxydopamine (6-OHDA) injection into the striatum induced a partial lesion of dopamine cells in the substantia nigra pars compacta (SNc) and fibers in the striatum. The GP firing rate decreased significantly with no significant change of the pattern. 6-OHDA injection into the SNc induced a total or subtotal lesion without any change in the firing rate and patterns of GP neurons. Concerning the STN, after partial lesion, the firing rate remained unchanged but the firing pattern significantly changed towards a more irregular and bursty pattern. In rats with total or subtotal lesion of the SNc the firing rate increased significantly and the relative amount of tonic neurons significantly decreased. Our results demonstrate that neuronal reactivity in the basal ganglia network considerably differs in the early versus late stage model of PD. We showed that the pathological activity of STN neurons after severe lesion is not mediated by the GP. Moreover, the unchanged activity of GP neurons is likely to be a consequence of the STN hyperactivity. These data suggest that in the GP-STN-GP network, the excitatory influence of the STN-GP pathway overrides that of the GABAergic GP-STN pathway, questioning the classical model of basal ganglia organization.</description><identifier>ISSN: 0014-4886</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1016/j.expneurol.2006.12.016</identifier><identifier>PMID: 17395181</identifier><identifier>CODEN: EXNEAC</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>6-Hydroxydopamine ; Animals ; Biological and medical sciences ; Corpus Striatum - pathology ; Disease Progression ; Dopamine - metabolism ; Drug toxicity and drugs side effects treatment ; Electrophysiology ; Extracellular recordings ; Globus pallidus ; Globus Pallidus - physiopathology ; Injuries of the nervous system and the skull. Diseases due to physical agents ; Male ; Medical sciences ; Microinjections ; Nerve Fibers - pathology ; Nerve Net - physiopathology ; Neurons ; Oxidopamine - administration &amp; dosage ; Parkinson Disease, Secondary - chemically induced ; Parkinson Disease, Secondary - pathology ; Parkinson Disease, Secondary - physiopathology ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; Striatum ; Substantia Nigra - metabolism ; Substantia Nigra - pathology ; Substantia nigra pars compacta ; Subthalamic nucleus ; Subthalamic Nucleus - physiopathology ; Toxicity: nervous system and muscle ; Traumas. Diseases due to physical agents</subject><ispartof>Experimental neurology, 2007-05, Vol.205 (1), p.36-47</ispartof><rights>2007 Elsevier Inc.</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-575a254b81f62f73cac0783bee82261c92f30b0e214392f36b8d4e6a1a01e6b73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0014488606006534$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18753387$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17395181$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Breit, S.</creatorcontrib><creatorcontrib>Bouali-Benazzouz, R.</creatorcontrib><creatorcontrib>Popa, R.C.</creatorcontrib><creatorcontrib>Gasser, T.</creatorcontrib><creatorcontrib>Benabid, A.L.</creatorcontrib><creatorcontrib>Benazzouz, A.</creatorcontrib><title>Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an early and in an advanced stage PD rat model. 6-Hydroxydopamine (6-OHDA) injection into the striatum induced a partial lesion of dopamine cells in the substantia nigra pars compacta (SNc) and fibers in the striatum. The GP firing rate decreased significantly with no significant change of the pattern. 6-OHDA injection into the SNc induced a total or subtotal lesion without any change in the firing rate and patterns of GP neurons. Concerning the STN, after partial lesion, the firing rate remained unchanged but the firing pattern significantly changed towards a more irregular and bursty pattern. In rats with total or subtotal lesion of the SNc the firing rate increased significantly and the relative amount of tonic neurons significantly decreased. Our results demonstrate that neuronal reactivity in the basal ganglia network considerably differs in the early versus late stage model of PD. We showed that the pathological activity of STN neurons after severe lesion is not mediated by the GP. Moreover, the unchanged activity of GP neurons is likely to be a consequence of the STN hyperactivity. These data suggest that in the GP-STN-GP network, the excitatory influence of the STN-GP pathway overrides that of the GABAergic GP-STN pathway, questioning the classical model of basal ganglia organization.</description><subject>6-Hydroxydopamine</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Corpus Striatum - pathology</subject><subject>Disease Progression</subject><subject>Dopamine - metabolism</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Electrophysiology</subject><subject>Extracellular recordings</subject><subject>Globus pallidus</subject><subject>Globus Pallidus - physiopathology</subject><subject>Injuries of the nervous system and the skull. Diseases due to physical agents</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microinjections</subject><subject>Nerve Fibers - pathology</subject><subject>Nerve Net - physiopathology</subject><subject>Neurons</subject><subject>Oxidopamine - administration &amp; dosage</subject><subject>Parkinson Disease, Secondary - chemically induced</subject><subject>Parkinson Disease, Secondary - pathology</subject><subject>Parkinson Disease, Secondary - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Striatum</subject><subject>Substantia Nigra - metabolism</subject><subject>Substantia Nigra - pathology</subject><subject>Substantia nigra pars compacta</subject><subject>Subthalamic nucleus</subject><subject>Subthalamic Nucleus - physiopathology</subject><subject>Toxicity: nervous system and muscle</subject><subject>Traumas. Diseases due to physical agents</subject><issn>0014-4886</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQxi1ERbeFV4Bc4JbgP4mTHKuqpZUqcaFna-JMWC_eONjOtnkY3hWnu6JHTrbm-32eGX-EfGK0YJTJr7sCn6cRZ-9swSmVBeNFqr8hG0ZbmvNS0LdkQykr87Jp5Dm5CGFHKW1LXr8j56wWbcUatiF_boYBdQyZGzKZb5feu-eldxPszYi5GftZY58FPKDHzPlsAh8N2MxiMG5cXXGL2Wh-eheiNxCTNkHcPsGSJf1FXMccUx10NAcTl9U1gbWmd3mYu7gFm9rpBMYn539l5ujzEN-TswFswA-n85I83t78uL7LH75_u7--esh1WjTmVV0Br8quYYPkQy00aFo3okNsOJdMt3wQtKPIWSnWu-yavkQJDChD2dXiknw5vjt593vGENXeBI3WwohuDoq1ouaSswTWR1CnfYPHQU3e7MEvilG1JqN26l8yak1GMa5SPTk_nlrM3R77V98pigR8PgEQNNjBw6hNeOWauhKiWWe9OnKYPuRg0KugDY4pJuNTkqp35r_D_AWeO7Sz</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Breit, S.</creator><creator>Bouali-Benazzouz, R.</creator><creator>Popa, R.C.</creator><creator>Gasser, T.</creator><creator>Benabid, A.L.</creator><creator>Benazzouz, A.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20070501</creationdate><title>Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat</title><author>Breit, S. ; Bouali-Benazzouz, R. ; Popa, R.C. ; Gasser, T. ; Benabid, A.L. ; Benazzouz, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-575a254b81f62f73cac0783bee82261c92f30b0e214392f36b8d4e6a1a01e6b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>6-Hydroxydopamine</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Corpus Striatum - pathology</topic><topic>Disease Progression</topic><topic>Dopamine - metabolism</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Electrophysiology</topic><topic>Extracellular recordings</topic><topic>Globus pallidus</topic><topic>Globus Pallidus - physiopathology</topic><topic>Injuries of the nervous system and the skull. Diseases due to physical agents</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microinjections</topic><topic>Nerve Fibers - pathology</topic><topic>Nerve Net - physiopathology</topic><topic>Neurons</topic><topic>Oxidopamine - administration &amp; dosage</topic><topic>Parkinson Disease, Secondary - chemically induced</topic><topic>Parkinson Disease, Secondary - pathology</topic><topic>Parkinson Disease, Secondary - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Striatum</topic><topic>Substantia Nigra - metabolism</topic><topic>Substantia Nigra - pathology</topic><topic>Substantia nigra pars compacta</topic><topic>Subthalamic nucleus</topic><topic>Subthalamic Nucleus - physiopathology</topic><topic>Toxicity: nervous system and muscle</topic><topic>Traumas. Diseases due to physical agents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Breit, S.</creatorcontrib><creatorcontrib>Bouali-Benazzouz, R.</creatorcontrib><creatorcontrib>Popa, R.C.</creatorcontrib><creatorcontrib>Gasser, T.</creatorcontrib><creatorcontrib>Benabid, A.L.</creatorcontrib><creatorcontrib>Benazzouz, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Breit, S.</au><au>Bouali-Benazzouz, R.</au><au>Popa, R.C.</au><au>Gasser, T.</au><au>Benabid, A.L.</au><au>Benazzouz, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>205</volume><issue>1</issue><spage>36</spage><epage>47</epage><pages>36-47</pages><issn>0014-4886</issn><eissn>1090-2430</eissn><coden>EXNEAC</coden><abstract>The origin of changes in the neuronal activity of the globus pallidus (GP) and the subthalamic nucleus (STN) in animal models of Parkinson's disease (PD) is still controversial. The aim of the study was to investigate the neuronal activity of STN and GP neurons under urethane anesthesia in an early and in an advanced stage PD rat model. 6-Hydroxydopamine (6-OHDA) injection into the striatum induced a partial lesion of dopamine cells in the substantia nigra pars compacta (SNc) and fibers in the striatum. The GP firing rate decreased significantly with no significant change of the pattern. 6-OHDA injection into the SNc induced a total or subtotal lesion without any change in the firing rate and patterns of GP neurons. Concerning the STN, after partial lesion, the firing rate remained unchanged but the firing pattern significantly changed towards a more irregular and bursty pattern. In rats with total or subtotal lesion of the SNc the firing rate increased significantly and the relative amount of tonic neurons significantly decreased. Our results demonstrate that neuronal reactivity in the basal ganglia network considerably differs in the early versus late stage model of PD. We showed that the pathological activity of STN neurons after severe lesion is not mediated by the GP. Moreover, the unchanged activity of GP neurons is likely to be a consequence of the STN hyperactivity. These data suggest that in the GP-STN-GP network, the excitatory influence of the STN-GP pathway overrides that of the GABAergic GP-STN pathway, questioning the classical model of basal ganglia organization.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>17395181</pmid><doi>10.1016/j.expneurol.2006.12.016</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4886
ispartof Experimental neurology, 2007-05, Vol.205 (1), p.36-47
issn 0014-4886
1090-2430
language eng
recordid cdi_proquest_miscellaneous_19372621
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects 6-Hydroxydopamine
Animals
Biological and medical sciences
Corpus Striatum - pathology
Disease Progression
Dopamine - metabolism
Drug toxicity and drugs side effects treatment
Electrophysiology
Extracellular recordings
Globus pallidus
Globus Pallidus - physiopathology
Injuries of the nervous system and the skull. Diseases due to physical agents
Male
Medical sciences
Microinjections
Nerve Fibers - pathology
Nerve Net - physiopathology
Neurons
Oxidopamine - administration & dosage
Parkinson Disease, Secondary - chemically induced
Parkinson Disease, Secondary - pathology
Parkinson Disease, Secondary - physiopathology
Pharmacology. Drug treatments
Rats
Rats, Wistar
Striatum
Substantia Nigra - metabolism
Substantia Nigra - pathology
Substantia nigra pars compacta
Subthalamic nucleus
Subthalamic Nucleus - physiopathology
Toxicity: nervous system and muscle
Traumas. Diseases due to physical agents
title Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T15%3A47%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%206-hydroxydopamine-induced%20severe%20or%20partial%20lesion%20of%20the%20nigrostriatal%20pathway%20on%20the%20neuronal%20activity%20of%20pallido-subthalamic%20network%20in%20the%20rat&rft.jtitle=Experimental%20neurology&rft.au=Breit,%20S.&rft.date=2007-05-01&rft.volume=205&rft.issue=1&rft.spage=36&rft.epage=47&rft.pages=36-47&rft.issn=0014-4886&rft.eissn=1090-2430&rft.coden=EXNEAC&rft_id=info:doi/10.1016/j.expneurol.2006.12.016&rft_dat=%3Cproquest_cross%3E19372621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19372621&rft_id=info:pmid/17395181&rft_els_id=S0014488606006534&rfr_iscdi=true